Is NeoCov a Covid Variant?
1 in 3 dies, Wuhan Scientists Warns.
28 January 2022.
New findings coming out and confirming the WHO director’s words, he has recently mentioned that “It’s the Ideal time for Variants”. This week started with BA.2 Sars-coV-2 new subvariant of Omicron which is called as “Son of Omicron” and yesterday (Jan 27 2022) Wuhan scientists warned of NeoCov new coronavirus variant.
According to a report by the Russian news agency Sputnik, scientists from China’s Wuhan, where the Covid-19 virus was identified in 2019. Have warned of a new strain of coronavirus called ‘NeoCov’ in South Africa, which is said to have a high death and transmission rate.
Scientists warn that the NeoCov coronavirus discovered in bats may pose a threat to people in the future.
Is it a New Sars-coV-2 Variant?
No. It was detected in outbreaks in Middle Eastern nations in 2012 and 2015, associated with the MERS-CoV -Middle East Respiratory Syndrome virus, similar to the SARS-CoV-2 virus, which causes infections in humans.
What is MERS-COV?
Middle East Respiratory Syndrome (MERS) is a new viral respiratory infection in humans. It was originally reported in 2012 in Saudi Arabia and has subsequently spread to several other nations, including the United States.
The majority of MERS-CoV infected persons experienced severe respiratory disease, including fever, coughing, and shortness of breath. Many of them have died.
According to WHO risk assessment about MERS-coV, Middle East respiratory syndrome (MERS) is a viral respiratory ailment that affects people and dromedary camels and is caused by the Middle East Respiratory Syndrome Coronavirus.
MERS-CoV infection can produce severe disease with a high fatality rate. Approximately 35% of MERS-CoV patients have died, but this may be an overestimation of the true mortality rate because mild cases of MERS-CoV may be missed by existing surveillance systems. And case fatality rates are only counted among laboratory-confirmed cases until more is known about the disease.
Humans become infected with MERS-CoV after coming into direct or indirect contact with dromedaries, the natural host and zoonotic source of MERS-CoV infection. MERS-CoV has shown the ability to spread between humans.
Where is NeoCov- MERS-coV found now?
While NeoCoV was discovered in a bat population in South Africa and has only been known to propagate among these animals, a new study published as a preprint on the bioRxiv website indicated that NeoCoV and its close related can also be found in humans.
According to Chinese scientists, NeoCoV has the potential to combine the high fatality rate of MERS-high CoV one in every three infected people dies and the rapid transmission rate of the existing SARS-CoV-2 coronavirus.
What did Wuhan Scientists report?
It was discovered that NeoCoV and it is near related, PDF-2180-CoV, can enter through particular forms of bat Angiotensin-converting enzyme 2 (ACE2) and human ACE2.
According to experts from Wuhan University and the Chinese Academy of Sciences, a single mutation is all that is required for the virus to invade human cells.
According to their results, the novel coronavirus poses a risk because it attaches to the ACE2 receptor differently than the COVID-19 pathogen. As a result, neither antibodies nor protein molecules generated in people who have had respiratory disease or who have been vaccinated against SARS-CoV-2 will provide effective protection.
“Given the significant changes in the RBD areas of the SARS-CoV-2 variations, particularly the severely mutated omicron variant,” the paper concluded, “these viruses may harbor a latent potential to infect people through additional adaptation via antigenic drift.”
“Our analysis indicates the first occurrence of ACE2 utilization in MERS-related viruses, shedding light on a potential bio-safety concern of the human emergence of an ACE2 using “MERS-CoV-2,” the researchers stated in the report.
“Immunity induced by prior infection or vaccination against other coronaviruses may be insufficient to protect people from NeoCoV and CoV infections. Because neither SARS-CoV-2 anti-sera nor ten tested anti-MERS-CoV nanobodies can cross-inhibit the infection caused by these two viruses,” the researchers concluded.
NeoCov, according to a study article published by Wuhan experts, is related to the Middle East respiratory illness or MERS-coronavirus. The paper has yet to be peer-reviewed and is available on the bioRxiv website.
According to the report, scientists from the Russian State Virology and Biotechnology Research Center published a statement on Thursday (27 January 2022) following a briefing on NeoCoV.
“The Vector research center is aware of the data obtained by Chinese researchers regarding the NeoCov coronavirus. It’s not about the emergence of a novel coronavirus capable of actively propagating among humans right now.” They went on to say that the Chinese team had identified potential dangers that needed to be investigated further.
MERS in the United States
MERS poses very minimal risk to the entire country of the United States. Only two people in the United States have ever tested positive for MERS-CoV infection, both in May 2014, whereas over 1,300 have tested negative.
In May 2014, the Centers for Disease Control and Prevention (CDC) verified two unrelated imported cases of MERS in the United States, one in Indiana and the other in Florida.
Both incidents occurred among Saudi healthcare providers who lived and worked in the country. Both came to the United States from Saudi Arabia, where scientists suspect they became infected. Both were hospitalized in the United States and were released after fully recovering. The CDC is still closely monitoring the issue.
Present vaccinations can protect NeoCov?
The study discovered that existing immunity or antibodies derived from vaccines or earlier Covid-19 infections may be ineffective in preventing NeoCov.
This is because NeoCov interacts with the ACE2 receptor differently than SARS-CoV-2. While the work has yet to be peer-reviewed, the findings have been recognized by the Russian State Virology and Biotechnology Research Center, which mentioned in a statement last week that further research was needed.
What did WHO say about this new study?
The World Health Organization (WHO) warned against drawing such conclusions until further study can be done.
“Whether the virus detected in the study will pose a risk for humans will require further study,” the organization has told TASS. Adding that it “works closely” with the World Organization for Animal Health (OIE), the Food and Agriculture Organization (FAO), and the UN Environment Program (UNEP) to “monitor and respond to the threat of emerging zoonotic viruses.”
“Animals, particularly wild animals are the source of more than 75% of all emerging infectious diseases in humans, many of which are caused by novel viruses,” the WHO said.
“Coronaviruses are often found in animals, including in bats which have been identified as a natural reservoir of many of these viruses,” the global body added.
NeoCov, according to Chinese scientists, can penetrate human cells in the same way as SARS-CoV-2.
Should we worry about this?
People already fighting against Sars-coV-2 the omicron variant with Vaccination, masks, and other tools provided by their specific country.
This study has yet to be reviewed, and that mutation still has not happened. This new study is about the threat in the future.
There is no need to worry about Neocov now.
*This article is an information update on the Global threat of coronavirus.